Summary
- Current Price
- As of today, JNJ price is $255.82, down -3.66% on
- Current Price All-Time High
- JNJ price is currently -6.94% below its historical high of $274.90 set on
- Market Cap
- JNJ current market cap is $617B, up +53.15% over the past 365 days
- PE Ratio
- JNJ current PE ratio is 29.65
- Revenue
- JNJ current annual revenue is $94.18B, up +6.03% year-over-year
- Next Earnings
- The next earnings release for JNJ is on
Profile
| Metric | Value |
|---|---|
| Full Name | Johnson & Johnson |
| Ticker | NYSE: JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | jnj.com |
| Employees | 138,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $255.82 | |
| Price, 1D Change | -3.66% | |
| Market Cap | $617B | |
| TTM Dividend Yield | 2.05% | |
| PE Ratio | 29.65 | |
| Beta | -0.19 | |
| Revenue | $94B | |
| Revenue, 1Y Change | +6.03% | |
| EPS | $11.03 | |
| EPS, 1Y Change | +90.56% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.34 | |
| Next Ex-Dividend | $1.34 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $11.03 | |
| EPS Estimate | N/A | $11.68 |
| EPS Est. Change | N/A | +5.82% |
| Revenue | $94.18B | |
| Revenue Estimate | N/A | $101.26B |
| Revenue Est. Change | N/A | +7.52% |
| Current Price | $255.82 | |
| Price Target | - | $274.00 |
| Price Tgt. Change | - | +7.11% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.96 | $5.79 | -41.85% | |
| $10.81 | $11.03 | +2.08% | |
| $11.68 | N/A | +5.82% | |
| $12.83 | N/A | +16.31% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $88.78B | $88.82B | +0.05% | |
| $93.76B | $94.18B | +0.45% | |
| $101.26B | N/A | +7.52% | |
| $108.38B | N/A | +15.08% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +52.95% | |
| Price, 3Y | +46.62% | |
| Market Cap, 1Y | +53.15% | |
| Market Cap, 3Y | +36.00% | |
| Revenue, 1Y | +6.03% | |
| Revenue, 3Y | +17.63% | |
| EPS, 1Y | +90.56% | |
| EPS, 3Y | +63.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $255.82 | |
| SMA 200 | $226.11 | |
| SMA 50 | $244.68 | |
| EMA 200 | $225.73 | |
| EMA 50 | $248.28 | |
| MACD | $4.53 | |
| Beta | -0.19 | |
| ATR | $6.50 | |
| 14-Day RSI | 51.77 | |
| 10-Day Volatility | 27.58% | |
| 1-Year Volatility | 18.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.34 | |
| Upcoming | $1.34 | |
| Dividend Yield | 2.01% | |
| Total Dividend | $5.14 | |
| Dividends Paid | $12.38B | |
| Payout Ratio | 46.19% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $94.18B | |
| EPS | $11.03 | |
| Gross Profit | $68.56B | |
| Gross Margin | 72.78% | |
| Operating Income | $25.60B | |
| Operating Margin | 27.17% | |
| Net Income | $26.80B | |
| Net Margin | 28.46% | |
| EBITDA | $33.63B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.61 | |
| Current Ratio | 1.03 | |
| Quick Ratio | 0.77 | |
| - | ||
| Piotroski F-Score | 7 | |
| Altman Z-Score | 5.24 |
Valuations
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $81.54B | |
| Cash & Equivalents | $20.10B | |
| Total Assets | $199.21B | |
| Current Assets | $55.62B | |
| Total Liabilities | $117.67B | |
| Current Liabilities | $54.13B | |
| Total Debt | $49.33B | |
| Short Term Debt | $8.50B | |
| Accounts Payable | $11.99B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $67.39B | |
| Operating Expenses | $42.96B | |
| Cost Of Goods Sold | $25.64B | |
| SG&A | $0.00 | |
| D&A | $7.50B | |
| Interest Expense | $0.00 | |
| Income Tax | $5.78B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $24.53B | |
| CFI | -$23.59B | |
| CFF | -$5.54B | |
| Capex | $4.83B | |
| Free Cash Flow | $19.70B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Raymond James | → | |
| Morgan Stanley | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| B of A Securities | → | |
| Morgan Stanley | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with JNJ
FAQ
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is NYSE:JNJ
Does Johnson & Johnson pay dividends?
Yes, Johnson & Johnson pays dividends. The last payment was $1.34, with an ex-dividend date on May 26, 2026
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector
What industry is Johnson & Johnson in?
Johnson & Johnson is in the General Drug Manufacturers industry
What country is Johnson & Johnson based in?
Johnson & Johnson is headquartered in United States
When did Johnson & Johnson go public?
Johnson & Johnson initial public offering (IPO) was on January 2, 1962
Is Johnson & Johnson in the S&P 500?
Yes, Johnson & Johnson is included in the S&P 500 index
Is Johnson & Johnson in the NASDAQ 100?
No, Johnson & Johnson is not included in the NASDAQ 100 index
Is Johnson & Johnson in the Dow Jones?
Yes, Johnson & Johnson is included in the Dow Jones index
When was Johnson & Johnson last earnings report?
Johnson & Johnson's most recent earnings report was on July 15, 2026
When does Johnson & Johnson report earnings?
The next expected earnings date for Johnson & Johnson is October 13, 2026
Data Sources & References
- JNJ Official Website www.jnj.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj
